arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

MIMEDX GROUP, INC.

MDXG
$3.27 ▲ +0.06 (+1.87%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
64 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
81
Health
Excellent
Bullish
auto_awesome

Analytical Summary

MIMEDX GROUP, INC. shows strong fundamentals with top-quartile Return on Common Equity (%) and Debt to Equity. The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $477.0M
Dividend Yield —
Revenue Growth -45.2% ↘
Op. Margin -18.8% ↗
ROIC -4.4% ↗
FCF / Share $0.03 ↗
Trailing P/E —
Price / Book 2.3x
FCF Yield 0.8%
Debt / Equity 0.00
info Valuation on last close. End-of-day price, Nov 5, 2026.

64-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$62.28M
↓ -45.2% —
Net Income Profit after all expenses
$-8.68M
↑ +41.5% —
Operating Margin Operating profit as % of sales
-18.8%
↑ +34.5% 67th
FCF / Share Free cash flow per share
$0.03
↑ +139.6% —
Long-Term Debt Long-term obligations
$0.00
↓ -100.0% —
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
71
Returns
85
Financial Health ↓
89
Cash Quality ↑
80

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 16 years · 64 quarters